您好,欢迎来到上海士研管理咨询有限公司
产业峰会 演讲局 专家智库服务 峰会活动服务 整合营销服务
  • 产业峰会:
    以专业团队对产业和市场客观详实地调研为前提,拥有战略性、系统性、全球性的基因,汇集了领导者关注的热点话题与领袖代表,为您提供“一站式”的对话、分享、社交平台!
  • 演讲局:
    致力于为全球企业和机构提供主题演讲家、高管大师班、董事会顾问,每项服务都提供了一种更深入、更具互动性的体验,尤其是针对较小的精选受众和关键个人。我们拥有最具影响力的商业领袖和顶级专家的资源,他们是各自领域的最杰出的代表。我们的团队由经验丰富的演讲和活动经理组成,我们注重建立长期而深入的伙伴关系。
  • 专家智库服务:
    中国领先的行业专家知识信息服务供应商,为需要专业洞见的商业决策者匹配具有一手经验的行业专家,助力他们以更加明确的目标和坚定的信心做出决策。我们有60万余名专家顾问遍布二十多个行业,而且每天还在增加!
  • 峰会活动服务:
    致力于成为全球最专业的产业峰会活动提供商,为企业和机构的产业性峰会活动提供一站式专业服务,包括调研策划、定制邀请、营销推广、运营组织、项目管理、直播与数字化会议等,每项服务都由经验丰富的专业团队匹配长期沉淀的产业资源予以卓越执行,我们注重建立长期而深入的伙伴关系。
  • 整合营销服务:
    致力于成为全球领先的2B营销服务机构,聚焦产业高端活动、内容、渠道的建设与沉淀,为客户提供一站式整合营销解决方案,助力企业线上线下获客与品牌筑造。我们深信专业团队匹配产业资源带来卓越执行,我们注重建立长期而深入的伙伴关系。
嘉宾信息
发布时间: 2021 - 07 - 20
点击次数: 0
所属职位: 首席医学官
所属公司: 江苏康宁杰瑞生物制药有限公司
个人简介:
Johannes Nippgen博士拥有25年临床肿瘤、临床开发,团队和项目管理经验, 在多家国际生物制药公司和生物技术公司担任重要职位, 并热衷于不断追求创新且始终致力于国际合作。加入康宁杰瑞前,他在默克生物制药担任中国研发中心负责人。Johannes Nippgen博士拥有德国维尔次堡大学博士学位、德国美因茨临床医学博士学位,在《新英格兰医学期刊》等多个国际学术期刊上发表过研究。Johannes Nippgen, MD, PhD, is Chief Medical Officer for Alphamab Oncology康宁杰瑞. He passionately aspires to innovation and improvement and strives towards bringing healthcare R&D in China to global leadership.After graduating in Medicine in Mainz, Germany, and earning his doctorate in Wurzburg, Germany, Johannes started his professional career as surgical oncologist. He holds German and European board certifications in Urology/ GU-oncology and published in various regional and international journals including the New England Journal of Medicine. Before joined Alphamab Oncology, he was the Head of R&D for Merck China.
发布时间: 2021 - 07 - 20
点击次数: 0
所属职位: CEO
所属公司: 甫康(上海)健康科技有限公司
个人简介:
沈孝坤博士,甫康药业公司CEO,毕业于武汉大学医学院获得临床医学和生物科学双学位,在中科院上海药物研究所获药理学博士学位。先后在恒瑞、诺华等国内外的知名企业从事过小分子和抗体新药研发,有10多年新药研发经验,主导和参与过抗肿瘤、免疫、皮肤等多种疾病领域新药的临床开发,并且帮助多个药物成功国内上市,其中包括First-In-Class的IL-17 抗体苏金单抗(Cosentyx)等。甫康药业公司是一家处于临床阶段的生物医药公司,研发具备“First-In-Class”和“Best-in-Class”潜力的新疗法,具备强大的新药研发与临床开发能力,立足中国,面向全球。Dr. Shen Xiaokun, CEO of Convalife Pharmaceutical Co., Ltd., graduated from Wuhan University with degrees in clinical medicine and Bioscience, and obtained Ph.D degree in pharmacology from Shanghai Institute of Materia Medica, CAS. Dr. Shen has been engaged in the research and development of new drugs for small molecules and antibodies in Hengrui, Novartis and other well-known enterprises. Dr. Shen has more than 10 years of experience in the research and development of new drugs. He has led and participated ~10 projects in the clinical development of new drugs in the fields of anti-tumor, immunity, dermatology and other diseases. He has also helped several drugs to be successfully NDA in China, including first in class IL-17 antibody, Cosentyx, etc.Convalife originated from Latin “valere”, meaning “value and strong”Convalife is an innovative, research-based, clinical stage biopharmaceutical company focused on bringing innovative therapies for cancer, autoimmune and infectious diseases to patients in China and around the world. Convalife develops new therapies with the potential of 'first in class' and 'best in class', and has strong new drug R & D and clinical development capabilities. Convalife obtained investment of famous listed companies such as Wuxibiologics (HK. 02269), Menovo Pharmaceutical (603538) etc.
发布时间: 2021 - 07 - 20
点击次数: 0
所属职位: 强生创新亚太区负责人
所属公司: 强生(中国)投资有限公司
个人简介:
王丹女士现任强生创新亚太区负责人,主要负责带领团队管理强生包括制药,医疗器械和消费品三大业务板块的早期创新投资组合,及创新生态系统和外部伙伴关系的拓展。王丹女士在生命科学领域拥有超过20年的丰富经验。在加入强生创新之前,王丹曾在美国BD医疗器械有限公司、易凯资本、快捷药方公司及强生等企业担任本地和全球研发、医学事务、临床研究和投资并购等重要领导职务。她在战略创新、确定新产品机遇和外部合作方面有着出色的业绩。王丹女士拥有北京大学MD和MSC学位,美国Emory大学Goizueta商学院的MBA学位和Rollins公共卫生学院的MPH学位.Dan Wang MD is the Head of Johnson & Johnson Innovation in Asia Pacific, responsible for managing a portfolio of co-investments spanning across all three business sectors and expanding external networks within the innovation ecosystem.Dan has over 20 years’ experience in the life sciences sector. Prior to joining Johnson & Johnson Innovation, Dan worked with Becton Dickinson (BD), e-Capital Corporation, Express Scripts and Johnson & Johnson by leading the local and global Research & Development, Medical Affairs and clinical research teams. Dan has a strong track record in strategic innovation, identifying new product opportunities and external partnerships.Dan holds MD and MSc degrees from Peking University as well as an MBA from Goizueta Business School, and an MPH from Rollins School of Public Health at Emory University, Atlanta.
发布时间: 2021 - 07 - 20
点击次数: 0
所属职位: 董事总经理、研究院副院长、医药行业首席分析师
所属公司: 兴业证券
个人简介:
徐佳熹,兴业证券董事总经理,研究院副院长、医药首席分析师,复旦大学生命科学学院博士,《药学进展》编委、上海市青年岗位能手、上海市青年金才。2011年加入兴业证券,公司覆盖全面,行业资源丰富。2016-2019年带领团队连续获得新财富最佳分析师第一名,2014-2018年最受保险机构欢迎分析师五连冠,并多次获得水晶球、Starmine、金牛奖、福布斯最佳分析师等奖项。
微信公众号
领导者网络APP
友情链接
Copyright ©2005 - 2017上海士研管理咨询有限公司
犀牛云提供企业云服务